In human and mouse CRC tumor models, high levels of PD-1 expression on TAM have low tumor phagocytosis, and treatment with checkpoint inhibitors targeting PD-1 or PD-L1 increases phagocytosis and reduces tumor growth [329]. Here, CD274 is linked to colorectal carcinoma.